[1]
Mega, T.P. e Silva, R.M. da 2023. Expenditure of biological drugs for rheumatoid arthritis treatment in the Brazilian public health system. Revista de Saúde Pública. 57, 1 (jul. 2023), 41. DOI:https://doi.org/10.11606/s1518-8787.2023057004280.